The spray helped with the headache during one attack, and I could keep working later that day. I disliked the bitter taste and had a blocked feeling in my nose for about half an hour.
Zomig
Zomig Nasal Spray is a prescription treatment for adults experiencing an acute migraine attack. Its nasal delivery can help when nausea or vomiting makes swallowing difficult. Zolmitriptan targets serotonin receptors involved in migraine to reduce headache pain and related symptoms.
Description
Zomig is a prescription nasal spray containing zolmitriptan for adults with acute migraine attacks, with or without aura. Zolmitriptan belongs to the triptan class, also called selective serotonin 5-HT1B/1D receptor agonists.
Composition
Zomig Nasal Spray contains zolmitriptan at a strength of 2.5 mg per dose. Zolmitriptan belongs to the triptan class, also called selective serotonin 5-HT1B/1D receptor agonists. Triptans are designed for the acute treatment of migraine rather than daily prevention.
During a migraine, several processes contribute to pain. Blood vessels around the brain can widen, trigeminal nerve pathways become active, and inflammatory chemical signals are released. Zolmitriptan acts on specific serotonin receptors in these pathways. This reduces trigeminal nerve signalling and helps reverse the vascular changes associated with migraine.
Zomig is intended for adults who have an established diagnosis of migraine and need treatment during an attack. It may be used for migraine with aura or migraine without aura, although it should not be used to prevent future attacks.
The nasal spray delivers zolmitriptan through the nasal lining. This avoids the need to swallow a tablet, which can be useful when nausea or vomiting is present.
Dosage and usage
The recommended adult starting dose is stated on the pack — follow the leaflet. The spray is used once for the initial dose.
A second dose may be used if the migraine returns or has not improved sufficiently, provided at least two hours have passed since the first dose. Follow the pack and leaflet instructions for the maximum dose in 24 hours. Frequent acute-medicine use can contribute to medication-overuse headache, so repeated attacks require review of the migraine plan.
Practical administration follows this sequence:
- Sit or stand upright.
- Gently clear excessive nasal discharge without forceful blowing.
- Close one nostril with a finger.
- Insert the spray tip into the other nostril.
- Press the device once while breathing in gently through the nose.
- Remove the device and breathe normally.
Do not spray into both nostrils for a single dose. Do not use Zomig every day to prevent migraine. Do not take a missed dose later, because Zomig is used when an attack occurs rather than on a fixed daily schedule.
A second dose is not suitable for every person. It should not be used when the first dose caused chest pressure, severe palpitations, a serious allergic reaction, or another concerning symptom. Nasal sprays should also be handled gently; inserting the tip deeply can irritate the nasal lining and cause bleeding.
How it works
Zolmitriptan activates 5-HT1B and 5-HT1D serotonin receptors. These receptors are found on blood vessels and nerve endings involved in migraine. Activation reduces the release of inflammatory neuropeptides and dampens signals travelling through the trigeminal system.
The drug does not work by general sedation or by masking pain in the same way as an opioid. Its effect is targeted toward migraine biology. The American Headache Society recognises triptans as established acute migraine treatments, while clinical response varies between individuals [2].
Indications
Zomig is used to treat an acute migraine episode after symptoms begin. It is not intended for routine daily use or for preventing migraine attacks between episodes. Clinical guidance from NICE supports triptans as acute treatments for suitable adults with migraine [1].
A migraine attack may involve several symptoms at the same time:
- Moderate or severe throbbing head pain
- Pain that worsens with normal activity
- Nausea or vomiting
- Sensitivity to light, known as photophobia
- Sensitivity to sound, known as phonophobia
- Visual, sensory, or speech symptoms during an aura
- Reduced ability to work, study, drive, or perform normal tasks
Zomig may relieve the headache and some associated symptoms because these symptoms share migraine-related nerve pathways. It does not treat every cause of headache. A sudden, unusually severe headache, a first neurological episode, new weakness, fainting, fever, or neck stiffness requires urgent medical assessment rather than self-treatment with a triptan.
A migraine may improve in stages. The pain can ease before sensitivity to light or nausea settles, and some people experience tiredness after the attack. Zomig may reduce the attack without removing the post-migraine fatigue that follows it. Response can vary between attacks. Persistent fatigue or a changing symptom pattern should be discussed with a clinician.
Comparison
Zomig belongs to a targeted migraine-treatment category. It differs from general painkillers because it acts on serotonin receptors involved in trigeminal nerve activation and migraine-related vascular changes.
Non-steroidal anti-inflammatory drugs may be useful for some mild or moderate attacks, while triptans are often selected when migraine pain is moderate to severe or has not responded adequately to simpler treatment. A clinician may choose a non-triptan option when cardiovascular contraindications, medication interactions, or previous triptan intolerance are present.
The nasal route may be considered when vomiting is prominent or swallowing is difficult. It may be less comfortable for someone with frequent nasal irritation or congestion. This is a clinical trade-off, not a reason to change the dose independently.
Contraindications
Zomig is not suitable for everyone. It is NOT for you if you have a listed cardiovascular contraindication, uncontrolled hypertension, or another condition that makes zolmitriptan unsuitable. It should not be used by a person with:
- Previous heart attack or ischaemic heart disease
- Coronary artery spasm or Prinzmetal angina
- Peripheral vascular disease
- Previous stroke or transient ischaemic attack
- Uncontrolled high blood pressure
- Certain hemiplegic or brainstem migraine diagnoses
- A serious previous allergic reaction to zolmitriptan
- Severe liver disease without specialist assessment
Zomig must not be combined with another triptan or an ergot-type migraine medicine within the same 24-hour period. Monoamine oxidase-A inhibitors can raise zolmitriptan exposure, and use within the relevant washout period is contraindicated under prescribing information. The FDA label also describes interaction precautions and cardiovascular contraindications for zolmitriptan [3].
Tell the prescriber about all medicines used for depression, anxiety, pain, or migraine. Selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants, and lithium may increase the risk of serotonin syndrome when combined with a triptan.
Pregnancy and breastfeeding require an individual assessment. The decision depends on the severity of migraine, previous treatment response, and available alternatives. Severe liver impairment can alter zolmitriptan exposure and may require a different treatment plan.
When this is not for you
Zomig may not be appropriate if you have heart or blood-vessel disease, uncontrolled high blood pressure, a previous stroke, certain types of migraine, severe liver disease, or a serious allergy to zolmitriptan. Do not use it with another triptan or an ergot-type migraine medicine within the same 24-hour period. Tell your prescriber if you take antidepressants, lithium, or other medicines for migraine, pain, or anxiety, or if you are pregnant or breastfeeding.
Side effects
Common effects after zolmitriptan can include:
- Altered taste after nasal administration
- Nasal or throat irritation
- Tingling or unusual skin sensations
- Dizziness
- Drowsiness
- Dry mouth
- A feeling of warmth or heaviness
- Temporary pressure in the throat, neck, chest, or jaw
Many of these effects are short-lived. Drowsiness and dizziness can affect driving, cycling, climbing, or work requiring precise concentration. Avoid driving until the response to Zomig is clear.
Chest, throat, jaw, or neck pressure can occur with triptans and may be temporary. Severe, persistent, or worsening chest pain requires urgent medical attention, especially in a person with cardiovascular risk factors. Palpitations, fainting, marked breathlessness, or weakness on one side of the body also require urgent assessment.
A dry mouth can feel worse during an attack because migraine-related nausea may reduce fluid intake. Small sips of water can help if drinking is tolerated. Do not force fluids during repeated vomiting; persistent vomiting may require medical treatment.
Rare but serious reactions include severe allergy, serotonin syndrome, heart attack, stroke, and dangerous changes in blood pressure. Serotonin syndrome is more likely when serotonergic medicines are combined and may involve agitation, sweating, tremor, fever, diarrhoea, muscle stiffness, or confusion.
Common mistakes
Several practical errors can reduce benefit or increase risk:
- Using Zomig before the headache phase when the treatment plan specifies use after pain begins
- Taking a second dose too soon
- Exceeding 10 mg in 24 hours
- Using Zomig every day as prevention
- Combining it with another triptan or an ergot medicine
- Driving after experiencing drowsiness or dizziness
- Ignoring new chest pain or neurological symptoms
- Treating every severe headache as migraine without reassessment
- Spraying into both nostrils for one dose
- Using the nasal device roughly and causing nasal injury
One easily missed detail is the 24-hour separation from other triptan or ergot medicines. A patient may remember the product name but overlook that a different migraine medicine belongs to the same restricted group.
Another common problem is waiting until vomiting is severe before treating the attack. Early planning matters, because a nasal route may be selected precisely when swallowing becomes difficult.
What doctors say
In clinical practice, doctors usually assess three points before prescribing a triptan: whether the headache pattern is genuinely migrainous, whether cardiovascular risks are acceptable, and whether the medicine is being used often enough to create medication-overuse headache.
A useful treatment plan includes more than the medicine itself. Patients may be advised to record the time an attack begins, the time Zomig is used, symptom improvement, side effects, and whether a second dose was needed. This record helps identify delayed treatment, poor response, frequent attacks, and possible triggers.
A doctor would also check whether the patient is using several medicines from the same category. Taking one triptan after another within the same day can increase adverse-effect risk without providing better relief.
Migraine treatment should be reviewed when attacks become more frequent, change character, last longer than usual, or require acute medicine on many days. Preventive treatment may be considered when attacks are frequent or disabling.
Frequently asked questions
Is Zomig used for migraine prevention?
Zomig is used for the acute treatment of an active migraine attack, not routine prevention. NICE guidance updated in 2025 continues to distinguish acute migraine medicines from preventive therapies. Taking zolmitriptan daily can increase adverse effects and may contribute to medication-overuse headache.
How quickly does Zomig Nasal Spray work?
The nasal route allows zolmitriptan to be absorbed through the nasal lining, and some patients begin to notice improvement within the first hour. The FDA prescribing information (2018) describes the clinical response pattern for zolmitriptan nasal spray, while individual onset varies with attack severity and timing. A persistent or worsening headache should not be treated with repeated unscheduled doses.
Can Zomig be used with antidepressants?
Zomig may interact with serotonergic antidepressants, including selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors. The FDA label revised in 2018 describes the potential for serotonin syndrome and the symptoms that require urgent assessment. These symptoms can include agitation, sweating, tremor, fever, diarrhoea, and muscle stiffness.
Can Zomig be used during pregnancy or breastfeeding?
Pregnancy and breastfeeding require a patient-specific assessment rather than an automatic decision. The Electronic Medicines Compendium product information for zolmitriptan (2024) describes reproductive considerations and the need to weigh maternal benefit against potential risk. Severe, untreated migraine can also affect wellbeing, so the treatment decision should consider the full clinical situation.
What should happen if Zomig causes chest pressure?
Mild, brief pressure can occur with triptans, but severe, persistent, or worsening chest pain requires urgent medical evaluation. The World Health Organization (2023) identifies cardiovascular disease as an important consideration in migraine treatment selection. Do not take another dose until the symptom has been assessed, especially if breathlessness, fainting, sweating, or pain spreading to the arm or jaw occurs.
Can Zomig be used with another migraine medicine?
Zomig should not be combined with another triptan or an ergot medicine within the same 24-hour period. The South African Health Products Regulatory Authority (2024), like other regulators, treats these combinations as a significant safety concern because of additive vascular effects. A separate non-triptan medicine may be appropriate for some people, but the combination should follow an agreed treatment plan.
Do you offer anonymous delivery?
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Comparison
Zomig: Reviews and Experiences
The first dose reduced the pain but did not remove the light sensitivity. I used a second dose after the required interval during one attack, then spoke with my doctor because I was needing acute treatment too often.
Swallowing tablets had become difficult when the nausea started. The nasal spray was easier to use, although dizziness meant I did not drive after taking it.
The migraine improved, but I noticed tingling and warmth shortly afterwards. Those sensations settled, yet I reported them before using another dose.
Sources
- National Institute for Health and Care Excellence (2025). Headaches in over 12s: diagnosis and management, NICE guideline CG150.
- American Headache Society (2015). The acute treatment of migraine in adults: the American Headache Society evidence assessment of migraine pharmacotherapies.
- U.S. Food and Drug Administration (2018). Zomig Nasal Spray — Prescribing Information.